Enflame
Enflame is an artificial intelligence start-up developing cloud-based deep learning chips for AI training platforms.
Enflame, founded in March, 2018 and headquartered in Shanghai, is an artificial intelligence neural network solution provider. Established by Zhao Lidong and Zhang Yalin, the company has received financings from Summitview Capital, Shivc, Redpoint China Ventures and so on. Rivals that have direct and indirect competition with Enflame globally include Cambrian, horizon, deephi tech, etc.
DeepBlue AI Robots Set to Enter Brazil
Recently, DeepBlue, a domestic artificial intelligence enterprise, announced a collaboration with a Brazilian client, marking the official entry of its intelligent robots into the Brazilian market to provide diverse intelligent services. This represents another significant milestone in DeepBlue's global strategic layout.
Updated 1 hour ago
AI Technology Provider RealAI Completes New Round of Strategic Financing
According to EqualOcean, recently, AI security infrastructure provider RealAI(瑞莱智慧) announced the completion of a new round of strategic financing, with investors including the Beijing Artificial Intelligence Industry Investment Fund(北京市人工智能产业投资基金).
Apr 18, 2024 01:27 PM
Knowdee Intelligence Completes Nearly CNY 100 Mn Pre-A Round Financing
EqualOcean has learned that on April 16th, Knowdee Intelligence(诺谛智能), a company focusing on the "AI + Manufacturing" sector, has successfully completed its Pre-A round of financing. This round of financing was led by Summitview Capital(武岳峰科创), with follow-up investments from Trilobite Venture Capital(三叶虫创投) and Tsingzhi Capital(清智资本), along with additional investment from Lenovo Group(联想集团), totaling nearly CNY 100 million.
Apr 17, 2024 06:20 PM
Microsoft Invests in UAE AI Giant G42, Achieving Multilevel Strategic Cooperation
Apr 16, 2024 06:21 PM
XPeng Motors "Largest Single Shipment in History" Dispatched to Germany
Apr 10, 2024 08:14 PM
BaishanCloud Announces Collaboration with Saudi Telecom Operator center3
Apr 09, 2024 06:13 PM
Synthetic Biology: Who Will Emerge as the Winner?
The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.
Jun 27, 2022 12:38 PM